Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02136498 · ClinicalTrials.gov registry record · NA
My Mobile Advice Program: A Randomized Pilot Feasibility Study
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02136498 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 66 participants.
The verdict
NCT02136498, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).
Interventions
- DRUG Varenicline
- BEHAVIORAL Cognitive-behavioral self-help
- BEHAVIORAL MyMAP (My Mobile Advice Program)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02136498
The ClinicalTrials.gov registry entry for NCT02136498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Varenicline is the first listed.
NCT02136498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02136498 about?
NCT02136498 is a clinical study titled "My Mobile Advice Program: A Randomized Pilot Feasibility Study". The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).
What is the current status of trial NCT02136498?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2014-10. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02136498?
The interventions under investigation include: Varenicline (DRUG), Cognitive-behavioral self-help (BEHAVIORAL), MyMAP (My Mobile Advice Program) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02136498?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.